跳至主要内容
临床试验/NCT00121355
NCT00121355已完成4 期

An Open-Label, Multi-Center, Prospective Cross-Over Study of Preference and Safety of NovoFine® Autocover(TM) Needles Compared to BD Safety Glide (TM) Syringes in the Hospital Setting

Novo Nordisk A/S2 个研究点 分布在 1 个国家目标入组 83 人开始时间: 2005年7月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
83
试验地点
2

研究概览

简要总结

This trial is conducted in the United States of America (USA). The aim of this trial is to examine whether nurses prefer to use the NovoFine® Autocover Needle or the BD Safety Glide (TM) Syringe (only) in a hospital setting. The number of needle stick injuries will also be evaluated and whether these hospital nurses prefer the safety features of the NovoFine® Autocover Needle versus those of the BD Safety Glide (TM) Syringe. The identified hospital nurses will evaluate the two types of needles during standard administration of insulin to patients being treated for diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hospital nurses with prior injection training without an infectious blood borne disease

排除标准

  • 未提供

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验